Preferred Label : Rhabdoid tumor predisposition syndrome 1;
Symbol : RTPS1;
CISMeF acronym : RDT; RTPS1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Brain tumor, posterior fossa, of infancy, familial;
Included titles and symbols : Malignant rhabdoid tumor, somatic; Rhabdoid tumor; Teratoid tumor, atypical; At/rt; RDT;
Description : The rhabdoid tumor predisposition syndrome is an autosomal dominant cancer syndrome
predisposing to renal or extrarenal malignant rhabdoid tumors and to a variety of
tumors of the central nervous system, including choroid plexus carcinoma, medulloblastoma,
and central primitive neuroectodermal tumors (Sevenet et al., 1999). Rhabdoid tumors
are a highly malignant group of neoplasms that usually occur in children less than
2 years of age. Malignant rhabdoid tumors (MRTs) of the kidney were first described
as a sarcomatous variant of Wilms tumors (Beckwith and Palmer, 1978). Later, extrarenal
rhabdoid tumor was reported in numerous locations, including the central nervous system
(CNS) (Parham et al., 1994). Classification has been difficult because of considerable
variation in the histologic and immunologic characteristics within and between rhabdoid
tumors of the liver, soft tissues, and CNS. In the CNS, rhabdoid tumors may be pure
rhabdoid tumors or a variant that has been designated atypical teratoid tumor (AT/RT).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the SWI/SNF-related, matrix-associated, actin-dependent regulator
of chromatin, subfamily B, member 1 gene (SMARCB1, 601607.0001);
Neoplasia : Rhabdoid tumors, malignant (renal or extrarenal); Atypical teratoid tumors; Choroid plexus carcinoma; Medulloblastoma;
Prefixed ID : #609322;
Origin ID : 609322;
UMLS CUI : C1836327;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT